Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities
Although cancer is still one of the most significant global challenges facing public health, the world still lacks complementary approaches that would significantly enhance the efficacy of standard anticancer therapies.
Wamidh H. Talib +7 more
doaj +1 more source
Ketogenic metabolic therapy as a candidate adjunct for CBTp delivery in schizophrenia spectrum disorders. [PDF]
Schizophrenia spectrum disorders (SSDs) are managed with pharmacotherapy alongside psychosocial interventions, including cognitive-behavioral therapy for psychosis (CBTp). In routine services, uptake and completion of CBTp remain limited, and participation barriers disrupt initiation, retention, and between-session follow-through.
Laurent N.
europepmc +2 more sources
Ketogenic metabolic therapy in conjunction with standard treatment for glioblastoma: A case report. [PDF]
Glioblastoma (GBM) is the most common primary malignant brain tumour in adults. The standard of care consists of surgical resection and concurrent chemoradiation, followed by adjuvant temozolomide chemotherapy. This protocol is associated with a median survival of 12-15 months, and 3 years.
Phillips MCL +4 more
europepmc +3 more sources
Ketogenic diet in the treatment of cancer – Where do we stand?
Background: Cancer is one of the greatest public health challenges worldwide, and we still lack complementary approaches to significantly enhance the efficacy of standard anticancer therapies.
Daniela D. Weber +5 more
doaj +1 more source
AbstractMetabolic epilepsies arise in the context of rare inborn errors of metabolism (IEM), notably glucose transporter type 1 deficiency syndrome, succinic semialdehyde dehydrogenase deficiency, pyruvate dehydrogenase complex deficiency, nonketotic hyperglycinemia, and mitochondrial cytopathies.
Gavrilovici, Cezar, Rho, Jong M
openaire +4 more sources
Background The low carbohydrate, high fat ketogenic diet can be an effective anticonvulsant treatment in some pediatric patients with pharmacoresistant epilepsy. Its mechanism(s) of action, however, remain uncertain.
Susan A. Masino +4 more
doaj +1 more source
Physiological activation of myeloid p38 controls macrophage IL‐12 production and crosstalk to the liver by modulating hepatic FGF21, and subsequently, brown adipose tissue thermogenesis during obesity Abstract Obesity features excessive fat accumulation in several body tissues and induces a state of chronic low‐grade inflammation that contributes to ...
María Crespo +14 more
wiley +1 more source
Remission of obsessive-compulsive disorder using ketogenic metabolic therapy in support of exposure and response prevention: a retrospective case report. [PDF]
Laurent N, Tague KA.
europepmc +2 more sources
Animal-based ketogenic diet puts severe anorexia nervosa into multi-year remission: A case series
Background: Anorexia nervosa is a devastating condition that increases risk of death over five-fold and is associated with a high rate of relapse. Considering the growing field of metabolic psychiatry, anorexia can be framed as a ‘metabolic-psychiatric ...
Nicholas G. Norwitz +2 more
doaj +1 more source
Transdiagnostic remission of psychiatric comorbidity in post-traumatic stress disorder, ADHD, and binge-eating disorder using ketogenic metabolic therapy: a retrospective case report. [PDF]
Bellamy EL, Laurent N.
europepmc +2 more sources

